Christina Y. Weng, MD, MBA is Professor of Ophthalmology and the Vitreoretinal Diseases & Surgery Fellowship Program Director at the Baylor College of Medicine in Houston, Texas. She has a faculty appointment at the Level 1 trauma center, Ben Taub General Hospital. Dr. Weng was a prior recipient of the Dan B. Jones Teaching Award. 

Dr. Weng graduated cum laude from Northwestern University and then went on to medical school at the University of Michigan where she was elected to the Alpha Omega Alpha (AOA) Medical Society. While in Ann Arbor, she pursued an MBA degree from the University of Michigan-Ross School of Business and graduated with high distinction. Dr. Weng completed her ophthalmology residency at the Wilmer Eye Institute-Johns Hopkins University and surgical retina fellowship at the Bascom Palmer Eye Institute-University of Miami. 

Dr. Weng is involved with multiple clinical trials and is the current national Protocol Chair of the DRCR Retina Network Protocol AO trial studying Home OCT.  She also leads numerous research studies in her areas of interest: clinical/surgical outcomes, gene therapy, medical economics, and telemedicine.  Dr. Weng serves on the Board of Directors of multiple organizations including the American Society of Retina Specialists (ASRS) and Women in Ophthalmology, and is the proud Co-Editor of the book Women in Ophthalmology: A Comprehensive Guide for Career and Life.   

Financial disclosure: Dr. Weng has/had an affiliation (financial or otherwise) with a commercial organization.

• Allergan/AbbVie, Alcon, Alimera Sciences, Genentech, Regeneron, REGENXBIO, Apellis, Iveric Bio/Astellas, EyePoint, Opthea - Consultant
• Funded Grants: GTC, DRCR Retina Network, Alimera Sciences - Contracted Research